Tong-Xie-Yao-Fang improves chronic intestinal fibrosis in mice with colitis through CRH-R2-mediated IL-6/STAT3 signaling pathway
Rattachement africain : cn. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Purpose: To investigate the potential mechanism of action of Tong-Xie-Yao-Fang (TXYF) on inflammation-related intestinal fibrosis in mice. In addition, to examine dextran sodium sulfate (DSS) induction and the stimulation of human intestinal fibroblasts (CCD-18Co) by transforming growth factorβ1 (TGF-β1). Methods: Chronic colitis in C57BL/6 mice was induced by administering 2 % DSS and TXYF extract (11.2 g/kg per day). An intestinal fibrosis cell model was constructed by stimulating CCD-18Co cells with TGF-β1 (10 ng/mL). The status and weight loss of colitis of the mice was assessed by Disease Activity Index (DAI) while colonic tissue injury and fibrosis were assessed using hematoxylin-eosin (H&E) staining and Masson’s trichrome staining. Relative expression levels of corticotrophin-releasing hormone receptor 2 (CRH-R2) and Interleukin 6 (IL-6)/signal transducer and activator of transcription 3 (STAT3) in colon tissues and CCD-18Co cells were determined using Western blot. A cell model of intestinal fibrosis was constructed by stimulating CCD-18Co cells with TGF-β1 (10 ng/mL). At the same time, the cells were subjected to the intervention of TXYF drug-containing serum (TXYF-DS). Results: TXYF significantly improve the pathological changes, weight loss, and DAI score of colon tissue in DSS induced colitis mice (p < 0.05). The expression levels of IL-6 and p-STAT3 were significantly reduced, while the expression level of CRH-R2 was upregulated in the mouse colon tissue (p < 0.05). At the cellular level, TXYF-DS intervention significantly reduced cell mortality and mitigated the degree of cell fibrosis (p < 0.05). Furthermore, the expression level of CRH-R2 was up-regulated while that of IL-6 and p-STAT3 were down-regulated. Conclusion: TXYF ameliorates chronic intestinal fibrosis in colitis-afflicted mice by restricting IL6/STAT3 signaling pathway whilst upregulating CRH-R2 expression
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Tong-Xie-Yao-Fang improves chronic intestinal fibrosis in mice with colitis through CRH-R2-mediated IL-6/STAT3 signaling pathway
- Date Crossref
- 06/09/2024
- Éditeur
- African Journals Online (AJOL)
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
Ningbo No. 2 Hospital pays non établi dans la noticeÉtablissement de santé
-
Ningbo Medical Center Lihuili Hospital pays non établi dans la noticeÉtablissement de santé
-
Zhejiang Chinese Medical University Department of Gastroenterology pays non établi dans la noticeUniversité ou école supérieure
-
Lihuili Hospital of Ningbo Medical Center Department of Gastroenterology pays non établi dans la noticeÉtablissement de santé
Ningbo No. 2 Hospital, Ningbo Medical Center Lihuili Hospital et Department of Gastroenterology — Zhejiang Chinese Medical University, avec 1 autre affiliation.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.